Are Remedium Life latest results good or bad?
Remedium Lifecare's latest results are concerning, with a Profit After Tax of Rs -1.88 crore and a 94.21% decline in net sales to Rs 81.57 crore, indicating significant operational challenges. Despite a slight improvement in standalone net profit, the overall financial performance remains negative.
Remedium Lifecare has reported its financial results for the quarter ending March 2025, which indicate significant challenges in its operational performance. The company's Profit After Tax (PAT) for the latest six months stands at Rs -1.88 crore, reflecting a drastic year-on-year decrease of 96.31%. This decline suggests ongoing difficulties in achieving profitability.In terms of net sales, Remedium Lifecare recorded Rs 81.57 crore for the quarter, which represents a substantial decline of 94.21% compared to the previous year. This sharp drop in sales is indicative of serious operational hurdles the company is facing.
Additionally, the company's standalone net profit showed a year-on-year growth of 95.09%, although it remains negative at Rs -2.64 crore. The operating profit margin, excluding other income, also reflects a negative trend, with a change of -2.49%.
Overall, the financial data highlights a concerning trajectory for Remedium Lifecare, as both PAT and net sales have shown substantial declines. Furthermore, the company saw an adjustment in its evaluation over the last three months, although the overall performance remains negative.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
